Literature DB >> 11721963

A new anti-hemoglobin F antibody against synthetic peptides for the detection of F-cell precursors (F-blasts) in bone marrow.

J W Choi1, Y Kim, M Fujino, M Ito.   

Abstract

To date there are few antibodies available for the detection of fetal hemoglobin (HbF)-containing erythroblasts (F-blasts) in paraffin-embedded hematopoietic tissues. Recently, we developed a new polyclonal antibody specific to F-blasts by immunization of a rabbit with synthetic peptides of human HbF. Specificity and reactivity of the antibody were confirmed by enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry. ELISA confirmed that the antibody showed strong immunoreactivity to fetal hemoglobin but no reaction to adult hemoglobin. The antibody could detect the presence of fetal blood hemolysates (10 microg/mL) at a dilution of 10(-5). According to immunohistochemical analysis, there were strong positive reactions to fetal erythroblasts in the liver and the spleen at 29 weeks of gestation and to erythroblasts from patients with myelodysplastic syndromes and erythroleukemia but no reactions to normal adult erythroblasts in bone marrow. Fetal erythrocytes in fetal blood vessels of placental tissues were strictly distinguished from maternal erythrocytes in the same sections by their positive reactions, indicating the presence of HbF. This new antibody will be a useful tool for studying fetal hemoglobin synthesis and for detecting F-blasts in archival specimens of various hematological diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11721963     DOI: 10.1007/bf02982061

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  11 in total

1.  Myelodysplastic syndrome with karyotype abnormality is associated with elevated F-cell production.

Authors:  J E Craig; M Sampietro; D G Oscier; M Contreras; S Thein
Journal:  Br J Haematol       Date:  1996-06       Impact factor: 6.998

Review 2.  Fetal hemoglobin levels in adults.

Authors:  J Rochette; J E Craig; S L Thein
Journal:  Blood Rev       Date:  1994-12       Impact factor: 8.250

Review 3.  Understanding fetal globin gene expression: a step towards effective HbF reactivation in haemoglobinopathies.

Authors:  S M Jane; J M Cunningham
Journal:  Br J Haematol       Date:  1998-07       Impact factor: 6.998

4.  Immunohistochemical identification of adult and fetal haemopoiesis in the spleen in lymphoma, leukaemia and myeloproliferative disease.

Authors:  J C Underwood; V J Dangerfield
Journal:  J Pathol       Date:  1981-05       Impact factor: 7.996

5.  F-cells in the adult: normal values and levels in individuals with hereditary and acquired elevations of Hb F.

Authors:  W G Wood; G Stamatoyannopoulos; G Lim; P E Nute
Journal:  Blood       Date:  1975-11       Impact factor: 22.113

6.  Fetal hemoglobin restriction to a few erythrocytes (F cells) in normal human adults.

Authors:  S H Boyer; T K Belding; L Margolet; A N Noyes
Journal:  Science       Date:  1975-04-25       Impact factor: 47.728

7.  A monoclonal antibody to hemoglobin F.

Authors:  H Muensch; T Hecht; K J Winkler; L Gaidulis; M Henke; K G Blume
Journal:  Blut       Date:  1984-09

8.  Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia.

Authors:  S Charache; G J Dover; R D Moore; S Eckert; S K Ballas; M Koshy; P F Milner; E P Orringer; G Phillips; O S Platt
Journal:  Blood       Date:  1992-05-15       Impact factor: 22.113

9.  Hemoglobin F in myelodysplastic syndrome.

Authors:  D Reinhardt; D Haase; C Schoch; S Wollenweber; E Hinkelmann; W v Heyden; G Lentini; B Wörmann; W Schröter; A Pekrun
Journal:  Ann Hematol       Date:  1998 Mar-Apr       Impact factor: 3.673

10.  An immunohistochemical study of hemoglobin A, hemoglobin F, muramidase, and transferrin in erythroid hyperplasia and neoplasia.

Authors:  M Forni; P R Meyer; N B Levy; R J Lukes; C R Taylor
Journal:  Am J Clin Pathol       Date:  1983-08       Impact factor: 2.493

View more
  3 in total

1.  F-blast is a useful marker for differentiating hypocellular refractory anemia from aplastic anemia.

Authors:  Jong Weon Choi; Masahiko Fujino; Masafumi Ito
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

Review 2.  The diagnosis from the pathological viewpoint of a blood disease.

Authors:  Masafumi Ito
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

3.  Developmental and species-divergent globin switching are driven by BCL11A.

Authors:  Vijay G Sankaran; Jian Xu; Tobias Ragoczy; Gregory C Ippolito; Carl R Walkley; Shanna D Maika; Yuko Fujiwara; Masafumi Ito; Mark Groudine; M A Bender; Philip W Tucker; Stuart H Orkin
Journal:  Nature       Date:  2009-08-05       Impact factor: 49.962

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.